Literature DB >> 11904382

Transcription-coupled and DNA damage-dependent ubiquitination of RNA polymerase II in vitro.

Keng-Boon Lee1, Dong Wang, Stephen J Lippard, Phillip A Sharp.   

Abstract

Transcription-coupled repair (TCR) is essential for the rapid, preferential removal of DNA damage in active genes. The large subunit of RNA polymerase (Pol) II is ubiquitinated in cells after UV-irradiation or cisplatin treatment, which induces DNA damage preferentially repaired by TCR. Several human mutations, such as Cockayne syndrome complementation groups A and B, are defective in TCR and incapable of Pol II ubiquitination upon DNA damage. Here we demonstrate a correlation between ubiquitination of RNA Pol II and arrest of transcription in vitro. Ubiquitination of Pol II is significantly induced by alpha-amanitin, an amatoxin that blocks Pol II elongation and causes its degradation in cells. Pol II undergoes similar ubiquitination on DNA containing cisplatin adducts that arrest transcription. Stimulation of ubiquitination requires the addition of template DNA and does not occur in the presence of an antibody to the general transcription factor TFIIB, indicating the transcription dependence of the reaction. We propose that components of the reaction recognize elongating Pol II-DNA complexes arrested by alpha-amanitin or cisplatin lesions, triggering ubiquitination.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11904382      PMCID: PMC123632          DOI: 10.1073/pnas.072068399

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  64 in total

Review 1.  The ubiquitin-mediated proteolytic pathway: mode of action and clinical implications.

Authors:  A Ciechanover; A Orian; A L Schwartz
Journal:  J Cell Biochem Suppl       Date:  2000

Review 2.  RING for destruction?

Authors:  P S Freemont
Journal:  Curr Biol       Date:  2000-01-27       Impact factor: 10.834

3.  Genetic analysis of BRCA1 function in a defined tumor cell line.

Authors:  R Scully; S Ganesan; K Vlasakova; J Chen; M Socolovsky; D M Livingston
Journal:  Mol Cell       Date:  1999-12       Impact factor: 17.970

4.  Repair of cisplatin--DNA adducts by the mammalian excision nuclease.

Authors:  D B Zamble; D Mu; J T Reardon; A Sancar; S J Lippard
Journal:  Biochemistry       Date:  1996-08-06       Impact factor: 3.162

5.  Brca1 controls homology-directed DNA repair.

Authors:  M E Moynahan; J W Chiu; B H Koller; M Jasin
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

6.  Transcription-coupled repair of 8-oxoguanine: requirement for XPG, TFIIH, and CSB and implications for Cockayne syndrome.

Authors:  F Le Page; E E Kwoh; A Avrutskaya; A Gentil; S A Leadon; A Sarasin; P K Cooper
Journal:  Cell       Date:  2000-04-14       Impact factor: 41.582

7.  Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin.

Authors:  P M Pil; S J Lippard
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

8.  Purification of nuclear proteins that bind to cisplatin-damaged DNA. Identity with high mobility group proteins 1 and 2.

Authors:  E N Hughes; B N Engelsberg; P C Billings
Journal:  J Biol Chem       Date:  1992-07-05       Impact factor: 5.157

9.  Promoter specificity of basal transcription factors.

Authors:  J D Parvin; H T Timmers; P A Sharp
Journal:  Cell       Date:  1992-03-20       Impact factor: 41.582

10.  A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage.

Authors:  S P Linke; K C Clarkin; A Di Leonardo; A Tsou; G M Wahl
Journal:  Genes Dev       Date:  1996-04-15       Impact factor: 11.361

View more
  52 in total

1.  The topoisomerase IIbeta circular clamp arrests transcription and signals a 26S proteasome pathway.

Authors:  Hai Xiao; Yong Mao; Shyamal D Desai; Nai Zhou; Chun-Yuan Ting; Jaulang Hwang; Leroy F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

Review 2.  Cockayne syndrome group B cellular and biochemical functions.

Authors:  Cecilie Löe Licht; Tinna Stevnsner; Vilhelm A Bohr
Journal:  Am J Hum Genet       Date:  2003-11-24       Impact factor: 11.025

3.  Physical and functional association of RNA polymerase II and the proteasome.

Authors:  Thomas G Gillette; Fernando Gonzalez; Agnes Delahodde; Stephen Albert Johnston; Thomas Kodadek
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-06       Impact factor: 11.205

4.  Interferon antagonist NSs of La Crosse virus triggers a DNA damage response-like degradation of transcribing RNA polymerase II.

Authors:  Paul Verbruggen; Marius Ruf; Gjon Blakqori; Anna K Överby; Martin Heidemann; Dirk Eick; Friedemann Weber
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

5.  BRCA1/BARD1 inhibition of mRNA 3' processing involves targeted degradation of RNA polymerase II.

Authors:  Frida E Kleiman; Foon Wu-Baer; Danae Fonseca; Syuzo Kaneko; Richard Baer; James L Manley
Journal:  Genes Dev       Date:  2005-05-15       Impact factor: 11.361

6.  A mechanism for transcriptional repression dependent on the BRCA1 E3 ubiquitin ligase.

Authors:  Andrew A Horwitz; El Bachir Affar; George F Heine; Yang Shi; Jeffrey D Parvin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-09       Impact factor: 11.205

7.  Multiple mechanisms contribute to inhibit transcription in response to DNA damage.

Authors:  George F Heine; Andrew A Horwitz; Jeffrey D Parvin
Journal:  J Biol Chem       Date:  2008-02-15       Impact factor: 5.157

Review 8.  Hypoxia inducible factor prolyl 4-hydroxylase enzymes: center stage in the battle against hypoxia, metabolic compromise and oxidative stress.

Authors:  Ambreena Siddiq; Leila R Aminova; Rajiv R Ratan
Journal:  Neurochem Res       Date:  2007-03-07       Impact factor: 3.996

Review 9.  Regulation of active genome integrity and expression by Rad26p.

Authors:  Shivani Malik; Sukesh R Bhaumik
Journal:  Nucleus       Date:  2014-10-31       Impact factor: 4.197

10.  Platinum complexes with imino ethers or cyclic ligands mimicking imino ethers: synthesis, in vitro antitumour activity, and DNA interaction properties.

Authors:  Francesco P Intini; Angelina Boccarelli; Valentina C Francia; Concetta Pacifico; Maria F Sivo; Giovanni Natile; Domenico Giordano; Pietro De Rinaldis; Mauro Coluccia
Journal:  J Biol Inorg Chem       Date:  2004-07-06       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.